Atmo Biosciences Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$12M
- Investors
-
8
Atmo Biosciences General Information
Description
Manufacturer of an ingestible gas-sensing capsule designed for monitoring gut health and microbiome function. The company's capsule provides real-time measurement of gaseous biomarkers, non-invasive assessment of gut transit times, a radiation-free diagnostic alternative, continuous monitoring during normal daily activities, multimodal onboard sensor signals for contractility mapping, enabling gastroenterologists to diagnose motility disorders quickly and accurately without invasive procedures.
Contact Information
Website
www.atmobiosciences.comCorporate Office
- 436 Elgar Road
- Box Hill, Victoria 3128
- Australia
Corporate Office
- 436 Elgar Road
- Box Hill, Victoria 3128
- Australia
Atmo Biosciences Timeline
Atmo Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 12-Aug-2026 | $12M | Completed | Generating Revenue | ||
| 9. Grant | 30-Apr-2025 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | 06-Nov-2023 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Apr-2023 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 30-Mar-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 12-Oct-2021 | Completed | Generating Revenue | |||
| 4. Grant | 01-Nov-2019 | Completed | Startup | |||
| 3. Accelerator/Incubator | 29-Oct-2019 | Completed | Startup | |||
| 2. Later Stage VC (Series A) | 29-Mar-2019 | $1.81M | $1.81M | Completed | Startup | |
| 1. Grant | 01-Jan-2018 | $84.2K | Completed | Startup |
Atmo Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference Shares | ||||||||
| Preference Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Atmo Biosciences Comparisons
Industry
Financing
Details
Atmo Biosciences Competitors (1)
One of Atmo Biosciences’s competitors is AnX Robotica, a Venture Capital-Backed company based in Plano, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AnX Robotica | Venture Capital-Backed | Plano, TX |
Atmo Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Atmo Biosciences Patents
Atmo Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025901889-A0 | Methods, programs, apparatus for initiating and performing vibration therapy in the large bowel | Pending | 16-May-2025 | ||
| AU-2025901888-A0 | Methods, programs, apparatus for predicting gi tract location of ingestible capsule by inertial motion sensing | Pending | 16-May-2025 | ||
| AU-2025900850-A0 | Methods, programs, apparatus for obtaining health information from sensors in an ingestible capsule | Pending | 17-Mar-2025 | ||
| WO-2026193522-A1 | Methods, programs, apparatus for obtaining health information from sensors in an ingestible capsule | Pending | 17-Mar-2025 | ||
| AU-2024900450-A0 | Methods, programs, apparatus for obtaining health information from sensors in an ingestible capsule | Inactive | 23-Feb-2024 |
Atmo Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Atmo Biosciences Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | |||
| Breakthrough Victoria | Venture Capital | Minority | ||
| Brisbane Angels | Angel Group | Minority | ||
| Otsuka Pharmaceutical | Corporation | Minority | ||
| Alium Capital Management | PE/Buyout | Minority |
Atmo Biosciences FAQs
-
When was Atmo Biosciences founded?
Atmo Biosciences was founded in 2012.
-
Where is Atmo Biosciences headquartered?
Atmo Biosciences is headquartered in Box Hill, Australia.
-
What is the size of Atmo Biosciences?
Atmo Biosciences has 31 total employees.
-
What industry is Atmo Biosciences in?
Atmo Biosciences’s primary industry is Diagnostic Equipment.
-
Is Atmo Biosciences a private or public company?
Atmo Biosciences is a Private company.
-
What is Atmo Biosciences’s current revenue?
The current revenue for Atmo Biosciences is .
-
How much funding has Atmo Biosciences raised over time?
Atmo Biosciences has raised $36.5M.
-
Who are Atmo Biosciences’s investors?
Johnson & Johnson Innovation - JLABS, Breakthrough Victoria, Brisbane Angels, Otsuka Pharmaceutical, and Alium Capital Management are 5 of 8 investors who have invested in Atmo Biosciences.
-
Who are Atmo Biosciences’s competitors?
AnX Robotica is a competitor of Atmo Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
